MADS® is now in the final prototype phase and is approaching readiness for clinical testing.
The tests will be conducted in close collaboration with leading surgical specialists at Rikshospitalet in Oslo, as well as cardiologists and nurses at Stavanger University Hospital (SUS).
What they all have in common is extensive experience with traditional abscess drainage and a strong desire for a more modern and forward-looking solution for treating patients with abscesses.
Initial laboratory tests show highly promising results!
Calculations indicate that MADS® can double the cleaning efficiency and drastically reduce treatment time for patients with abscesses. In addition, MADS® is very gentle on the patient, increasing the quality and reducing the discomfort associated with abscess treatments.
Madsnor collaborates closely with the innovation company Validé and the health technology company Yallow Life Science. We are currently seeking investors and strategic partners to help bring the MADS® technology to market.
.svg)
.svg)
.svg)
.svg)
.svg)